Condition
Dual Antiplatelet Therapy clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Dual Antiplatelet Therapy clinical trials that are recruiting, at sites in 8 countries (most in South Korea (2), Italy (2), China (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 8Countries
Newest Dual Antiplatelet Therapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients | — | Milan, MI | Recruiting | Aug 2, 2024 |
| Evaluating 1-year Dual Antiplatelet Therapy after GENOSS® Stent Implantation in Heart Disease Patients | — | Wŏnju, Gangwon State | Recruiting | Oct 10, 2023 |
| Evaluating short-term dual antiplatelet therapy after a specific heart stent implantation | — | Wŏnju, Gangwon State | Recruiting | Oct 10, 2023 |
| 24-month versus 12-month dual antiplatelet therapy after drug-eluting stent in people with high Lipoprotein(a) | — | Beijing, Beijing Municipality | Recruiting | Aug 28, 2023 |
| Comparing short-term and standard antiplatelet therapy in heart attack patients | Phase 4 | Bonheiden and 26 other locations | Recruiting | Aug 8, 2022 |
All recruiting trials (5)
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
Evaluating 1-year Dual Antiplatelet Therapy after GENOSS® Stent Implantation in Heart Disease Patients
This study is testing whether a year of dual antiplatelet therapy after getting a GENOSS® stent helps heart disease patients stay healthy and avoid serious heart problems.
-
Evaluating short-term dual antiplatelet therapy after a specific heart stent implantation
This study is testing whether a short period of dual antiplatelet therapy after getting a specific heart stent can keep patients with coronary artery disease safe and healthy over a year.
-
24-month versus 12-month dual antiplatelet therapy after drug-eluting stent in people with high Lipoprotein(a)
This trial will test whether continuing dual antiplatelet therapy for 24 months instead of 12 months lowers the risk of death, heart attack, or stroke in people with high Lipoprotein(a) who had a drug-eluting stent and were event-free at one year.
-
Comparing short-term and standard antiplatelet therapy in heart attack patients
This study tests whether a shorter course of a specific heart medication can help heart attack patients recover as well as the standard longer treatment.
Related topics
Quick answers
How many Dual Antiplatelet Therapy clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in South Korea (2 trials), Italy (2 trials), China (1 trial), Belgium (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.